Vaccine Makers Promote Use of Artificial Intelligence for Development
Artificial Intelligence assists in the development of vaccine research and trial testing, makers say.

Artificial Intelligence assists in the development of vaccine research and trial testing, makers say.
WASHINGTON, December 15, 2021 – Artificial intelligence is helping accelerate the development of COVID-19 vaccines.
Permitting delays, transmission backlogs, siting fights, and supply chain gaps top the list.
The agency is investigating the company, along with Comcast and Verizon, over diversity practices.
Outdated permitting systems could stymie nuclear projects needed for tomorrow’s data centers, panelists said.
Latency experienced by users is dependent in part on their distance from internet exchange points.